Clinical Trials
4 trialsNCT03423628 2025-12-22
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
AstraZeneca
Phase 1 Recruiting
NCT07098806 2025-08-01
CA2024-LM-001
Plus Therapeutics
Phase 1 Recruiting
NCT05414123 2023-10-16
FORESEE
Biocept, Inc.
Terminated
NCT03613181 2023-04-24
ANGLeD
Angiochem Inc
Phase 3 Unknown